Back to Search
NORMAN WOLMARK, MD
MD
Surgical Oncology Physician
NPI: 1528060357Individual
Specialties, Licenses & Credentials
Surgical Oncology PhysicianPrimary
Surgery — Surgical Oncology
Code: 2086X0206X
MD014918E(PA)
Surgery Physician
Surgery
Code: 208600000X
MD014918E(PA)
Research & Publications (20)
National Surgical Adjuvant Breast and Bowel Project trials in colon cancer.
PMID 11273592·Semin Oncol·2001
8-other
The role of tamoxifen in breast cancer prevention: issues sparked by the NSABP Breast Cancer Prevention Trial (P-1).
PMID 11795386·Ann N Y Acad Sci·2001
3-trial
Preoperative chemotherapy in patients with operable breast cancer: nine-year results from National Surgical Adjuvant Breast and Bowel Project B-18.
PMID 11773300·J Natl Cancer Inst Monogr·2001
3-trial
Randomized trial of postoperative adjuvant chemotherapy with or without radiotherapy for carcinoma of the rectum: National Surgical Adjuvant Breast and Bowel Project Protocol R-02.
PMID 10699069·J Natl Cancer Inst·2000
3-trial
Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in patients treated by breast-conserving therapy in five National Surgical Adjuvant Breast and Bowel Project protocols of node-negative breast cancer.
PMID 19349544·J Clin Oncol·2009
2-rct
Cancer survivorship research: the challenge of recruiting adult long term cancer survivors from a cooperative clinical trials group.
PMID 19526347·J Cancer Surviv·2009
4-observational
Hazard of recurrence and adjuvant treatment effects over time in lymph node-negative breast cancer.
PMID 18830816·Breast Cancer Res Treat·2009
8-other
Amenorrhea in premenopausal women on the doxorubicin-and-cyclophosphamide-followed-by-docetaxel arm of NSABP B-30 trial.
PMID 18302020·Breast Cancer Res Treat·2009
4-observational
Evaluation of microtubule-associated protein-Tau expression as a prognostic and predictive marker in the NSABP-B 28 randomized clinical trial.
PMID 19667268·J Clin Oncol·2009
8-other
The use of tamoxifen and raloxifene for the prevention of breast cancer.
PMID 19213563·Recent Results Cancer Res·2009
6-review
Initial safety report of NSABP C-08: A randomized phase III study of modified FOLFOX6 with or without bevacizumab for the adjuvant treatment of patients with stage II or III colon cancer.
PMID 19414665·J Clin Oncol·2009
3-trial
A randomized clinical trial of adjuvant chemotherapy for radically resected locoregional relapse of breast cancer: IBCSG 27-02, BIG 1-02, and NSABP B-37.
PMID 18650162·Clin Breast Cancer·2008
2-rct
Gemcitabine/epirubicin/paclitaxel as neoadjuvant chemotherapy in locally advanced breast cancer: a phase II trial of the NSABP Foundation Research Group.
PMID 18650156·Clin Breast Cancer·2008
3-trial
HER2 status and benefit from adjuvant trastuzumab in breast cancer.
PMID 18367751·N Engl J Med·2008
8-other
Benefit from exemestane as extended adjuvant therapy after 5 years of adjuvant tamoxifen: intention-to-treat analysis of the National Surgical Adjuvant Breast And Bowel Project B-33 trial.
PMID 18332472·J Clin Oncol·2008
4-observational
Chemosensitivity and stratification by a five monoclonal antibody immunohistochemistry test in the NSABP B14 and B20 trials.
PMID 18927301·Clin Cancer Res·2008
4-observational
FOLFOX and FLOX regimens for the adjuvant treatment of resected stage II and III colon cancer.
PMID 18798075·Cancer Invest·2008
6-review
The half century of clinical trials of the National Surgical Adjuvant Breast And Bowel Project.
PMID 18929150·Semin Oncol·2008
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 320 E NORTH AVE
PITTSBURGH, PA 15212 - Phone
- (412) 359-3336
Quick Facts
- NPI
- 1528060357
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile